Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
IMUC > SEC Filings for IMUC > Form 8-K on 2-Mar-2016All Recent SEC Filings




Change in Directors or Principal Officers

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On February 25, 2016, ImmunoCellular Therapeutics, Ltd. (the "Company") and Dr. John Yu entered into an Amended and Restated Independent Contractor Services Agreement ("Agreement"), which is effective as of February 1, 2016 and supersedes the previous agreement dated October 1, 2015, which was previously disclosed in the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on October 7, 2015. Under the Agreement, Dr. Yu will continue providing consulting services to the Company, including supporting the execution of the phase 3 clinical trial of ICT-107 and assisting with the evaluation and acquisition of outside technology. Dr. Yu will receive a fee of $5,000 per month. The term of the Agreement expires on July 31, 2016, and may be terminated by either party upon 30 days prior written notice. Either party may also terminate the Agreement immediately upon written notice to the other party upon a material breach of the Agreement.

  Add IMUC to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for IMUC - All Recent SEC Filings
Copyright © 2017 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.